| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0580672B1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
| 01/08/1997 | EP0558657B1 Retroviral protease inhibitors |
| 01/08/1997 | EP0551411B1 Ionically cross-linked polymeric microcapsules |
| 01/08/1997 | EP0538394B1 Treatment of male infertility |
| 01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 |
| 01/08/1997 | EP0386044B1 Hypoglycaemic peptides |
| 01/08/1997 | EP0341273B1 Biological materials, processes for producing biological materials and for using such materials in therapy |
| 01/08/1997 | EP0268636B1 Polynucleotide sequences encoding the human FC RECEPTOR FOR IMMUNOGLOBULIN |
| 01/08/1997 | CN1139955A Human kunitz-type protease inhibitors |
| 01/08/1997 | CN1139933A Interleukin-6 (iL-6) antagonists |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139931A Cyclic neurokinin a antagonists |
| 01/08/1997 | CN1139917A Calcium receptor-active arylalkyl amines |
| 01/08/1997 | CN1139871A Novel apopotsis-modulating proteins, DNA encoding the proteins and methods of use thereof |
| 01/08/1997 | CN1139578A Making method for insulin suppository |
| 01/08/1997 | CN1139577A Usage of Barch mycin used as animal growth-promoting agent and its combination |
| 01/08/1997 | CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/08/1997 | CN1033759C 猪生长激素类似物 Porcine growth hormone analog |
| 01/08/1997 | CN1033738C Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing same |
| 01/07/1997 | US5591891 N-[Mercaptoacyl (amino acid or peptide ) ] compounds and S-lipophiIic aliphatic carbonyl derivatives thereof as antihypertensives |
| 01/07/1997 | US5591884 Dopamine agonists |
| 01/07/1997 | US5591860 Retroviral protease inhibiting compounds |
| 01/07/1997 | US5591851 Antiviral compounds |
| 01/07/1997 | US5591838 Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients |
| 01/07/1997 | US5591831 Medical diagnosing, drug screening |
| 01/07/1997 | US5591829 Antibodies modified with toxic substance |
| 01/07/1997 | US5591828 Genetic engineering |
| 01/07/1997 | US5591827 Interleukin-6 receptor antagonists |
| 01/07/1997 | US5591826 Responsible for colorectal cancer |
| 01/07/1997 | US5591825 Dna and transducers |
| 01/07/1997 | US5591824 Porcine apamin binding protein/receptor |
| 01/07/1997 | US5591758 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 01/07/1997 | US5591739 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
| 01/07/1997 | US5591728 New phosphonic acid compounds |
| 01/07/1997 | US5591720 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/1997 | US5591719 Method for treating acute and chronic inflammatory disorders using polypeptides with fibronectin activity |
| 01/07/1997 | US5591718 Neutrophil activating factors |
| 01/07/1997 | US5591717 Branched apogenic peptide for inducing apoptosis |
| 01/07/1997 | US5591716 Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins |
| 01/07/1997 | US5591715 Fatty diester, diamide or diether of polyoxyethylene glycol |
| 01/07/1997 | US5591714 Derivatives of A82846 |
| 01/07/1997 | US5591713 Water-soluble composition for sustained-release |
| 01/07/1997 | US5591711 Lysine-glycine-histidine tripeptide, fibroblast proliferation |
| 01/07/1997 | US5591710 Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
| 01/07/1997 | US5591709 Compositions and methods for treating wounds |
| 01/07/1997 | US5591641 Nucleic acid encoding the growth hormone releasing hormone receptor |
| 01/07/1997 | US5591640 Functional DNA block and plasmid coding for hirudin, transformed yeast, method for preparing hirudin, hirudin obtained and its pharmaceutical use |
| 01/07/1997 | US5591633 Nucleic acids encoding human placental coagulation inhibitor (PCI) |
| 01/07/1997 | US5591632 Recombinant BCG |
| 01/07/1997 | US5591631 Anthrax toxin fusion proteins, nucleic acid encoding same |
| 01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination |
| 01/07/1997 | US5591624 Retroviral packaging cell lines |
| 01/07/1997 | US5591623 Oligonucleotide modulation of cell adhesion |
| 01/07/1997 | US5591603 Process for preparing aprotinin and aprotinin analogs in yeast cells |
| 01/07/1997 | US5591602 Nucleic acid encoding opioid receptor |
| 01/07/1997 | US5591600 Antisense inhibitors of the human immunodeficiency virus |
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
| 01/07/1997 | US5591592 Method for detection of fibronectin receptor ligands |
| 01/07/1997 | US5591583 Human restrictin and nucleic acid sequences |
| 01/07/1997 | US5591574 Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50 |
| 01/07/1997 | US5591453 Incorporation of biologically active molecules into bioactive glasses |
| 01/07/1997 | US5591446 Methods and agents for the prophylaxis of atopy |
| 01/07/1997 | US5591444 Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 01/07/1997 | US5591433 Oral administration of immunologically active biomolecules and other therapeutic proteins |
| 01/07/1997 | US5591432 Antibody to the neural cell adhesion molecule and methods of use |
| 01/07/1997 | US5591431 Enhancement of clot lysis |
| 01/07/1997 | US5591430 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 01/07/1997 | US5591427 Modulating proliferation, differentiation, or activation of cells |
| 01/07/1997 | CA2079585C Ligand for the neu gene product |
| 01/07/1997 | CA2025315C Protein-containing aqueous solutions |
| 01/07/1997 | CA2004606C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 01/07/1997 | CA1338836C Endotoxin binding protein and uses thereof |
| 01/03/1997 | WO1997000328A1 Modified porphyroproteins |
| 01/03/1997 | WO1997000323A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 01/03/1997 | WO1997000321A1 Immune response modulators and uses therefor |
| 01/03/1997 | WO1997000320A1 Modified polypeptide, dna encoding the same, transformant, and medicinal composition containing the polypeptide |
| 01/03/1997 | WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | WO1997000318A1 Osteoclast growth regulatory factor |
| 01/03/1997 | WO1997000317A1 Osteoclast growth regulatory factor |
| 01/03/1997 | WO1997000315A1 MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASE cDNAs AND THEIR BIOLOGICALLY ACTIVE EXPRESSION PRODUCTS |
| 01/03/1997 | WO1997000271A1 Novel high affinity human antibodies to tumor antigens |
| 01/03/1997 | WO1997000270A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 01/03/1997 | WO1997000269A1 New family of linear antimicrobial peptides from hagfish intestine |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000084A1 Nonimmunogenic mhc-blocking peptides |
| 01/03/1997 | WO1997000083A1 Method of treating cd4+ t cell lymphopenia in immuno-compromised patients |
| 01/03/1997 | WO1997000082A1 Novel use of collagenase |
| 01/03/1997 | WO1997000081A1 A method for inhibiting bacteremia and bacterial dissemination |
| 01/03/1997 | WO1997000080A1 Pharmaceutical preparation with cyclosporin a |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000078A1 Methods of preventing or treating allergies |
| 01/03/1997 | WO1997000077A1 Anti-metastatic and anti-angiogenic pharmaceutical compositions |
| 01/03/1997 | WO1997000071A1 Androgenic directed compositions |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |
| 01/03/1997 | WO1996037621A3 Multimeric proteins |
| 01/03/1997 | WO1996034965A3 Chimeric mcp and daf proteins with cell surface localizing domain |
| 01/03/1997 | CA2245835A1 Novel high affinity human antibodies to tumor antigens |
| 01/03/1997 | CA2225484A1 Androgenic directed compositions |